JeffreyArnoldMoscowMD
Pediatric Hematology & Oncology • Lexington, KYSenior Investigator, National Cancer Institute
Dr. Moscow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
740 Rose St
Lexington, KY 40536Phone+1 859-257-7910
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1983 - 1985- University of Texas Southwestern Medical CenterInternship, Pediatrics, 1982 - 1983
Geisel School of Medicine at DartmouthClass of 1982
Certifications & Licensure
MD State Medical License 1988 - 2023
KY State Medical License 1998 - 2017- American Board of Pediatrics Pediatrics
Clinical Trials
- Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor.Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, Eric M Jones, Li Chen
SLAS Discovery. 2024-10-01 - 1 citationsRandomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, David J Kwiatkowski, Shiven Patel
Lung Cancer. 2024-09-01 - 1 citationsA Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.Brian S White, Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B Neuhauser
Cancer Research. 2024-07-02
Press Mentions
- NIH Initiative to Test New Cancer Drug CombinationsJune 3rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
